Black Diamond Therapeutics Inc (BDTX)

Black Diamond Therapeutics Inc (BDTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $105M; returns 1 day -9.6%, 1 week +9.3%, 1 year -51.5%.

Black Diamond Therapeutics is a clinical-stage oncology company focused on developing MasterKey therapies targeting families of oncogenic mutations. Their MasterKey therapies are designed to address genetically defined tumors, overcome resistance, minimize toxicities, and penetrate the brain to treat CNS diseases.

Groups BDTX belongs to

• Clinical Stage Biotech
• Oncology
• Biotechnology
• Cancer Therapeutics
• Clinical Stage
• Healthcare
• Biopharmaceutical
• Precision Medicine
• CNS Disorders
• Life Sciences

BDTX financial model: income statement, cash flow and balance sheet